The FDA has granted a “Fast Track” designation to rezpegaldesleukin (REZPEG) as a treatment for severe-to-very severe ...

Nektar Therapeutics (Nasdaq: NKTR) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for rezpegaldesleukin for the treatment of severe-to-very severe ...

Those who get their hair back after an episode of alopecia probably didn’t have moderate to severe hair loss. Learn about ...

The FDA granted fast track designation for rezpegaldesleukin for treating adults and children aged 12 years and older, ...

Nektar Therapeutics (NASDAQ:NKTR) has announced that the FDA has awarded Fast Track designation to its experimental drug ...

Recent advancements in dermatology have highlighted the crucial role of dermal T cell immunity in regulating hair follicle ...

Alopecia areata is an autoimmune disorder that usually results in unpredictable, patchy hair loss. Approximately 7 million people in the U.S. have alopecia areata, and it can affect anyone of any ...

New treatment for teens with alopecia The FDA approved the once-daily pill called Litfulo, created by pharmaceutical giant Pfizer, for people 12 and up to treat severe alopecia areata, or at least ...

Until now. The FDA has approved what experts are calling a groundbreaking treatment for severe alopecia areata, making it the only medication on the market approved for the skin disease. 0:00 1:28 ...

Alopecia is an umbrella term for hair loss, and alopecia areata (AA) is a common cause of hair loss that can affect anyone at any age. It usually results in small, round patches of baldness on the ...

Can alopecia areata be cured? "Sadly not. Alopecia areata is an unpredictable condition, and the pathways behind it are not fully understood; treatments often help, but curing it cannot be guaranteed.